🇺🇸 FDA
Pipeline program

FST-201 (dexamethasone 0.1%) Otic Suspension

FST201-AFOE-02

Phase 3 small_molecule terminated

Quick answer

FST-201 (dexamethasone 0.1%) Otic Suspension for Acute Fungal Otitis Externa is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Acute Fungal Otitis Externa
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials